Tower Research Capital (TRC)’s Zymergen Inc. Common Stock ZY Stock Holding History

Tower Research Capital (TRC)’s Portfolio ZY Stock Details ZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,778	Closed	-$10K	–	6903
2022 Q3	$10K	Sell	3,778 -18,754	-83%	-$45.5K	﹤0.01%	4622
2022 Q2	$28K	Buy	22,532 +13,236	+142%	+$22.2K	﹤0.01%	3464
2022 Q1	$27K	Buy	9,296 +7,278	+361%	+$30.9K	﹤0.01%	3271
2021 Q4	$14K	Sell	2,018 -3,110	-61%	-$30.2K	﹤0.01%	4137
2021 Q3	$67K	Buy	5,128 +1,377	+37%	+$29.2K	﹤0.01%	2734
2021 Q2	$150K	Buy	+3,751	New	+$148K	﹤0.01%	2131

Tower Research Capital (TRC)'s ZY Position: Q4 2022 in Review

Tower Research Capital (TRC) sold out of Zymergen Inc. Common Stock (ZY) in Q4 2022, closing a stake of 3,778 shares — an estimated $10K sold.

Tower Research Capital (TRC) first reported a position in ZY in Q2 2021 and held it in 6 quarters. The position peaked at $150K in Q2 2021. 0 funds tracked by Wall St. Rank hold ZY as of Q4 2022.

Tower Research Capital (TRC) reported no remaining Zymergen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Tower Research Capital (TRC) sold 3,778 Zymergen Inc. Common Stock shares in Q4 2022, an estimated $10K.
Tower Research Capital (TRC) first reported a position in Zymergen Inc. Common Stock in Q2 2021 and held it in 6 quarters.
Tower Research Capital (TRC)'s Zymergen Inc. Common Stock position peaked at $150K in Q2 2021.
0 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q4 2022.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.